SCHEMBL19212196

SCHEMBL19212196

Cc1cc(N2CCN(C(=O)O)CC2)ccc1CC#N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.44
GAA P10253 2/20 0.44
ALDH1A1 P00352 3/20 0.42
GFER P55789 1/20 0.42
RORC P51449 2/20 0.41
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
KDM4E B2RXH2 3/20 0.39
LMNA P02545 3/20 0.39
TSHR P16473 1/20 0.39
MEN1 O00255 1/20 0.39
TNNI3 P19429 1/20 0.39
TNNT2 P45379 1/20 0.39
TNNC1 P63316 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CTSB P07858 2/20 0.38
CTSK P43235 2/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29707320 0.83 MAPT (0.50) MAPTALDH1A1MAPK1HTTLMNA
SCHEMBL19212262 0.83 MAPT (0.50) MAPTALDH1A1MAPK1HTTLMNA
SCHEMBL19212277 0.80 MAPT (0.45) MAPTGAAALDH1A1GFERRORC
SCHEMBL2021224 0.78 MAPT (0.66) MAPTGAAALDH1A1GFERMAPK1
SCHEMBL15265036 0.76 GRIN2B (0.51) MAPTALDH1A1GFERKDM4ELMNA
SCHEMBL17801223 0.76 MAPT (0.51) MAPTGAAALDH1A1GFERMAPK1
SCHEMBL4014464 0.76 MAPT (0.49) MAPTALDH1A1MAPK1HTTKDM4E
SCHEMBL28747907 0.75 MAPT (0.50) MAPTGAAALDH1A1GFERMAPK1
SCHEMBL11299225 0.75 GAA (0.59) MAPTGAAALDH1A1GFERMAPK1
SCHEMBL21802553 0.73 MAPT (0.53) MAPTGAAALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414252-A1 THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS Forma Therapeutics, Inc. (US) 2018-12-19 EP disclosed
WO-2017139778-A1 THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS FORMA THERAPEUTICS, INC. (US) 2017-08-17 WO disclosed